Recall Radar
All recallsMedicine & devices

Dabigatran Etexilate Capsules, 75 mg, 60-count (6x10)blister pack further packaged in a carton, Rx only, Manufactured by: Alkem Laboratories Ltd., Mumbai, INDIA, Distributed by: M…

Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability

Class III Medicine & devices FDA August 5, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
Ascend Laboratories, LLC — Bedminster, NJ
Severity
Class III — low
Reported
August 5, 2026
Quantity
924 cartons x 12 x 6 x 10 (in blister pack)
Recall number
D-0738-2026
Status
Ongoing
Source
FDA

Where it went

USA Nationwide

Other medicine & devices recalls

See every current recall on the live dashboard →